Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.57
-0.09 (-1.59%)
Nov 16, 2026, 4:00 PM EST - Market closed

Myriad Genetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
803.6824.5837.6753.2678.4690.6
Revenue Growth
-2.63%-1.56%11.21%11.03%-1.77%23.99%
Cost of Revenue
254.5247.9252.2236.2202197.6
Gross Profit
549.1576.6585.4517476.4493
Selling, General & Admin
552.1537.6560572.9514.7537.8
Research & Development
104.1106.8113.488.785.481.9
Operating Expenses
656.2644.4673.4661.6600.1619.7
Operating Income
-107.1-67.8-88-144.6-123.7-126.7
Interest Expense
-16.7-10.5-2.8-2.9-3.2-6.6
Interest & Investment Income
2.51.81.72.52.60.7
Other Non Operating Income (Expenses)
0.20.81.1-4.40.6-0.6
EBT Excluding Unusual Items
-121.1-75.7-88-149.4-123.7-133.2
Impairment of Goodwill
-4.5-234.7---16.9-1.8
Gain (Loss) on Sale of Assets
---13.8--151.6
Asset Writedown
-3.6-84.7-43---
Legal Settlements
--21.3-112.8--62
Other Unusual Items
------11.7
Pretax Income
-129.2-395.1-123.5-262.2-140.6-57.1
Income Tax Expense
-0.1-29.23.81.1-28.6-29.9
Earnings From Continuing Operations
-129.1-365.9-127.3-263.3-112-27.2
Net Income
-129.1-365.9-127.3-263.3-112-27.2
Net Income to Common
-129.1-365.9-127.3-263.3-112-27.2
Net Income Growth
------
Shares Outstanding (Basic)
949391838178
Shares Outstanding (Diluted)
949391838178
Shares Change
2.66%2.21%9.42%2.73%3.33%4.31%
EPS (Basic)
-1.37-3.95-1.41-3.18-1.39-0.35
EPS (Diluted)
-1.37-3.95-1.41-3.18-1.39-0.35
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-33.9-13.8-27.7-174.1-151.60.6
Free Cash Flow Per Share
-0.36-0.15-0.31-2.10-1.880.01
Gross Margin
68.33%69.93%69.89%68.64%70.22%71.39%
Operating Margin
-13.33%-8.22%-10.51%-19.20%-18.23%-18.35%
Profit Margin
-16.06%-44.38%-15.20%-34.96%-16.51%-3.94%
Free Cash Flow Margin
-4.22%-1.67%-3.31%-23.11%-22.35%0.09%
EBITDA
-56.9-14.1-26.8-82.7-71-63.9
EBITDA Margin
-7.08%-1.71%-3.20%-10.98%-10.47%-9.25%
D&A For EBITDA
50.253.761.261.952.762.8
EBIT
-107.1-67.8-88-144.6-123.7-126.7
EBIT Margin
-13.33%-8.22%-10.51%-19.20%-18.23%-18.35%
Revenue as Reported
-----690.6
Advertising Expenses
-10.110.38.55.3-
SEC Filings: 10-K · 10-Q